Select country set
language
Menu Shopping cart 0,00 Search
Distributed product

CIC C3d ELISA

  • Regulatory status:RUO
  • Type:ELISA
  • Other names:C3d-linked CIC, circulating immune complexes C3d
  • Species:Human
Please select your region to see available products and prices.
Cat. No. Size Price


New DKO017 96 wells (1 kit)
PubMed Product Details
Technical Data

Type

ELISA

Applications

Serum, Plasma

Sample Requirements

10 µl/well

Shipping

Shipped on ice packs. Upon receipt, store the product at the temperature recommended below.

Storage/Expiration

Store the complete kit at 2 – 8 °C. Under these conditions, all components are stable until the expiration date (see label on the box).

Calibration Range

0 - 16 - 64 µgEq/mL

Limit of Detection

1 µgEq/mL

Intra-assay (Within-Run)

n=16
CV ≤ 6.1%

Inter-assay (Run-to-Run)

n=6
CV ≤ 13.0%

Spiking Recovery

94 - 105%

Summary

Features

European Union: for in vitro diagnostic use

Rest of the world: for research use only!

The total assay time is less than 1.5 hours

Quantitative determination of CIC C3d concentration in human serum or plasma

Assay format is 96 wells

Quality Controls (positive and negative) are ready to use

Standards are ready to use

For routine analysis

Research topic

Immune Response, Infection and Inflammation

Summary

The complement system might play a role in many diseases with an immune component, such as Barraquer-Simons Syndrome Alzheimer's disease, asthma, lupus erythematosus, various forms of arthritis, autoimmune heart disease and multiple sclerosis. Deficiencies of the terminal pathway predispose to both autoimmune disease and infections (particularly meningitis). C3d binds covalently to erythrocytes (E-C3d) to form a stable long-lived cell-bound marker. Cross-sectional and longitudinal studies have found that measurement of these cell-bound complement activation products is useful in monitoring disease activity.

Related Products Docs